Cargando…
Upfront Treatment of Pediatric High-Risk Neuroblastoma With Chemotherapy, Surgery, and Radiotherapy Combination: The CCCG-NB-2014 Protocol
PURPOSE: The Chinese Children’s Cancer Group developed the CCCG-NB-2014 study to formulate optimal treatment strategies for high-risk (HR) neuroblastoma (NB). The safety and efficacy of this protocol were evaluated. METHOD: Patients with newly diagnosed neuroblastoma and defined as HR according to t...
Autores principales: | Zhang, Dongdong, Kaweme, Natasha Mupeta, Duan, Peng, Dong, Youhong, Yuan, Xiaojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634583/ https://www.ncbi.nlm.nih.gov/pubmed/34868944 http://dx.doi.org/10.3389/fonc.2021.745794 |
Ejemplares similares
-
Prognostic significance of steroid response in pediatric acute lymphoblastic leukemia: The CCCG-ALL-2015 study
por: Chu, Jinhua, et al.
Publicado: (2022) -
Leukapheresis and Hyperleukocytosis, Past and Future
por: Zhang, Dongdong, et al.
Publicado: (2021) -
A Novel Risk Defining System for Pediatric T-Cell Acute Lymphoblastic Leukemia From CCCG-ALL-2015 Group
por: Liu, Xiaoming, et al.
Publicado: (2022) -
Pygo2 as a novel biomarker in gastric cancer for monitoring drug resistance by upregulating MDR1
por: Zhang, Dongdong, et al.
Publicado: (2021) -
Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment
por: Kaweme, Natasha Mupeta, et al.
Publicado: (2021)